Today: 19 April 2026
Glencore share price slips as Chevron Singapore sale talks and Rio Tinto bid clock keep GLEN.L in focus
22 January 2026
2 mins read

Glencore share price slips as Chevron Singapore sale talks and Rio Tinto bid clock keep GLEN.L in focus

London, January 22, 2026, 08:13 GMT — Regular session

  • Glencore slipped 0.9% in early trading Thursday, following a close at 500.00 pence
  • Reuters reports Glencore and Eneos are in final negotiations to acquire Chevron’s downstream assets in Singapore
  • The spotlight remains on takeover-code disclosures as Rio Tinto’s Feb. 5 deadline approaches

Glencore (GLEN.L) shares dropped 0.9% to 495.48 pence by 0813 GMT, pulling back from Wednesday’s close at 500.00 pence. The stock hovered just under the peak of its 52-week range, fluctuating in an early session band between 495.45 and 500.50 pence.

The drop followed Reuters’ report that Chevron is in the final stages of talks with Japan’s Eneos and Glencore over its refining and distribution assets in Singapore. Sources indicated the deal could top $1 billion. The assets include Chevron’s 50% stake in Singapore Refining Co, which has a capacity of about 290,000 barrels per day.

The key point now: Glencore’s trading has shifted from a steady FTSE miner to more of a deal-driven play. Its marketing division covers oil, metals, and freight, and investors are weighing whether fresh downstream assets would boost resilience or simply pile on risk at a delicate moment in the cycle.

Another key factor is the ticking takeover clock. Rio Tinto is currently in merger talks with Glencore and, under UK takeover rules, faces a Feb. 5 deadline to either make a formal offer or walk away — a “put up or shut up” moment that pressures a clear decision. Rio’s recent production update also caught attention. Analyst Glyn Lawcock at Barrenjoey described it as “a solid quarter” that “beat across the board” in its main business lines. Reuters

Deal chatter has sparked a wave of mandatory disclosures. Under Rule 8.3 of the UK Takeover Code, anyone holding 1% or more of relevant securities must file an opening position disclosure by 3:30 p.m. London time this Thursday. Simply put, these filings force major shareholders to reveal their stakes once an “offer period” kicks off. lse.co.uk

Commodity prices remain a key factor, though the mood is still unsettled. Copper bounced back Wednesday after a steep fall the day before, with tight inventories outside the U.S. drawing attention. Neil Welsh, head of metals at Britannia Global Markets, noted that “structural tightness continues to underpin prices.” For diversified players like Glencore, this environment can flip investor sentiment rapidly—from “cash machine” to “cyclical headache.” Reuters

That said, the deal cuts both ways. Any downstream purchase of Chevron’s Singapore assets will probably be scrutinized for price, funding, and alignment with Glencore’s shareholder return strategy—especially as investors continue pushing for tighter discipline from miners and traders.

There’s a downside too: if Rio pulls out on Feb. 5, the takeover premium baked into Glencore’s shares could vanish quickly. Plus, if copper’s rally loses steam, the broader mining sector’s macro support might disappear along with it.

Glencore investors will get the full-year production report for 2025 on January 29, released at 7:00 a.m. UK time. The company’s preliminary results are set to follow on February 18.

Stock Market Today

  • Brown-Forman (BF.B) Faces Valuation Debate After Strong Short-Term Rally
    April 18, 2026, 9:26 PM EDT. Brown-Forman's (BF.B) stock surged about 27% in one month, reversing last year's roughly 11% decline. The recent sharp rebound contrasts with a weaker long-term trend, highlighting momentum shifts. Despite shares trading near analyst price targets at $29.15, fair value estimates diverge widely. Simply Wall St's discounted cash flow (DCF) model values Brown-Forman at $37.78, suggesting undervaluation, while another model pegs fair value at $21.00, indicating the stock is roughly 39% overvalued. The gap reflects differing views on declining global alcohol consumption due to rising health awareness, which could pressure Brown-Forman's revenue growth. However, premium spirits and emerging market demand might offset some risks. Investors face critical decisions amid mixed signals, weighing whether current prices embed growth prospects or overestimate future earnings.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update
Previous Story

Compass Group shares rise in early London trade: what the CPG stock price move says ahead of Feb 5 update

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”
Next Story

BT share price jumps as Openreach steps up copper switch-off — UBS still says “sell”

Go toTop